TELA Bio Inc. (TELA)
NASDAQ: TELAHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
TELA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $31.11M
- EPS (TTM)
- -$0.74
- Dividend yield
- None
- 52-week range
- 0.501 – 1.50
- Day range
- 0.6721 – 0.8098
- Volume / Avg
- 119.05K / 217.44K
- Beta
- —
- Shares outstanding
- 45.19M
52-week range
TELA stock today
On Nov 20, TELA ended the session at $0.6885, shedding $0.0383 (5.27%), versus the S&P 500's 3.70% decline. At this level, TELA sits near the bottom of its 52-week range of $0.501 to $1.50: 54.1% below the high, set on Sep 23, 2026 and 37.4% above the low. TELA is down 41.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 41.2%.
TELA Bio has posted a net loss over the last twelve months (EPS of -$0.74), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About TELA Bio
Company profileTELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Ms. Heather C. Getz CPA, M.B.A.
- Headquarters
- Malvern, PA
- Employees
- 218
- IPO year
- 2019
- Website
- telabio.com
Financial highlights
Full financialsIn fiscal 2025, TELA Bio generated $80.3 million in revenue, up 15.8% from fiscal 2024, its 8th consecutive year of revenue growth. TELA Bio reported a net loss of $38.8 million, compared with a loss of $37.8 million a year earlier. Gross margin was 67.7% (up from 67.1%) and operating margin -42.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $80.28M | $69.30M | $58.45M | $41.42M | $29.46M |
| Growth | +15.84% | +18.56% | +41.13% | +40.58% | +61.77% |
| Net income | $-38.83M | $-37.84M | $-46.66M | $-44.30M | $-33.28M |
| EPS (diluted) | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 |
Analyst forecast
ForecastConsensus (6 analysts)
strong_buy
Avg. price target
$2.08+202.11%
- Strong buy 1
- Buy 4
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 10, 2026
- EPS actual vs est.
- $-0.16 vs $-0.19
- Surprise
- +15.79%
TELA news
All TELA newsTELA Bio peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XTNTXtant Medical Holdings Inc. | 0.21 | -2.82% | $29.49M | vs TELA |
| NSPRInspireMD Inc. | 0.54 | -12.97% | $29.23M | vs TELA |
| MDAISpectral AI Inc. Class A | 1.04 | -20.61% | $33.47M | vs TELA |
| NEPHNephros Inc. | 2.61 | -8.10% | $28.37M | vs TELA |
| SRTSSensus Healthcare Inc. | 2.26 | -4.24% | $37.20M | vs TELA |
| PLRZPolyrizon Ltd. | 9.31 | -8.42% | $22.61M | vs TELA |
| DAVIDavion Healthcare Plc | 0.9001 | -9.99% | $22.50M | vs TELA |
| DXRDaxor Corporation | 7.45 | -7.33% | $43.49M | vs TELA |
Indexes, lists and sector
TELA Bio stock FAQ
What is TELA Bio's stock price today?
TELA last traded at $0.6885 as of Nov 20, 4:00 PM EST, down 5.27% on the day. Prices are delayed at least 15 minutes.
Who is TELA Bio's CEO?
Ms. Heather C. Getz CPA, M.B.A. is the chief executive officer of TELA Bio Inc., which has about 218 employees.
What is the TELA 52-week high?
The 52-week high for TELA is $1.50 and the 52-week low is $0.501. The stock is currently 54.1% below its high.